Asumi HD Inc (229A) Cotización

https://www.youtube.com/watch?v=4ymPHzIkvug

That's the other shoe that will drop just like they did in the previous MARINE Patents trial. Only this time we hope our counsel will be ready for schenanegans like cropped tables. 

While the following is true "You will have to recapture all the depreciation and capital gains" except 0% Rate: Single filers with taxable income up to $48,350; Married filing jointly up to $96,700; Married filing separately up to $48,3503. This means for example if one is married and over 65 person

I don't suspect we see 2.50 again till after the BR filing, all the other ETF filings are non events!

Nice day

So where to next? Lower support line in my charts, which, I know you see!

Nice day

Be safe!

Up to like 7 or 8 fires now NOPEY well over 10 now

https://media3.giphy.com/media/f6W3eijFZUIwiNY0xp/giphy.gif?cid=6c09b952klfx6y7jxsop94baxo5k1w85a23kjntrjlfprodb&ep=v1_internal_gif_by_id&rid=giphy.gif&ct=g

Yeah, perhaps the guy is fabricating the story. But like you said, you wouldn't be at all surprised if it were true. And to even think it is, is pretty telling.

Seems like a new 2024 annual report is added

https://s204.q4cdn.com/707617056/files/doc_financials/2024/ar/8e6783e2-86ea-429d-90cc-46b2afae5e0d.pdf

Yve's answer to whether the product is ready? "We think so", is a defense. Like I say, it'll be interesting to watch an expert witness testify against expert witness, grifter, misguider, dr, dr lebby.

Thanks for sharing pgsd.
https://x.com/Siobhain_Mc/status/1900610727351615512

https://commonslibrary.parliament.uk/research-briefings/cbp-10198/

You're not the only one wondering why the MHRA is taking so long. Even MP Siobhain McDonagh called their performance on glioblastoma 'woeful' and questioned whether they should be abolished altogether.

March 13
https://x.com/Siobhain_Mc/status/1900226965656813953

On top of Missling having no fallback revenue opportunities without EMA approval from current trials, a share buyback would be just about the best way to erode the company's cash balance and ability to fund new trials.

PROFOUND Implications of CO Mingling two heretofore separate & distinct therapies
CELL & GENE ( latter is approaching a decade in development & approved in many blood cancers)

Perhaps why $NWBO MAESTRO spent 2 years in negotiations for mid 2024 Cross Licensing with Roswell Pa

wth

https://www.youtube.com/watch?v=xZlxOvHwcq0

wow.....that was 9 years ago.....Now what ?
https://www.mining.com/pdac-jv-video-dundee-sustainables-clevr-chemistry-cuts-gold-extraction-time-to-an-hour/
Holy
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ca%3Adst&x=0&y=0&time=100&startd

Misery loves company and the 5 of them are surely miserable with their 99% losses.

FACTS are always here to trump their bullshit.

Can you believe this POS is down 99%, loses over $100,000 per month, has no cash and no sources of funding except for one Taiwanese dude, an

Interesting, care to share actual proof attorneys are posting at this BioAmber Inc fka BIOAQ forum.

Attorneys posting on a indepted shell for half a decade.

Putin wants Ukrainian troops in the Kursk region to surrender as part of the peace deal. I don't see how that going to go over big with Ukraine.

https://www.aljazeera.com/news/2025/3/14/putin-says-russia-will-spare-ukrainian-forces-in-kursk-if-they-surrender

https://www

I think the most important job (funding wise) for Dan and Keith right now would be to get that 30% Pickle Crow interest monetized. That has got to be worth something in the current gold environment because Pickle Crow is almost a 3m ounce deposit and FFMG is basically being free carried all the way

Is this fluff post an honest disclosure.

https://x.com/WinningCEO/status/1900742819272175711

Eric will do his best now to convince you his business is flying, back in full mode. Posts with him thanking a store for their business with pics, vids, whatever. Details ? like

Are you for real, dude? 'Cause that was funny!

I'm still thinking you're a bot.